Solubility and stability of taxol: Effects of buffers and cyclodextrins

International Journal of Pharmaceutics

Volumn 133, Issue 1-2, 1996, Pages 191-201

  Dordunoo, Stephen K ^a,b   Burt, Helen M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Angiogenesis Technologies Inc   (Canada)

Author keywords

Cyclodextrins complexation; pH stability; Solubility; Taxol

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BUFFER; CYCLODEXTRIN; GAMMA CYCLODEXTRIN; GAMMA CYCLODEXTRIN DERIVATIVE; PACLITAXEL; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; DRUG DEGRADATION; DRUG SOLUBILITY; DRUG STABILITY; HYDROLYSIS; MASS SPECTROMETRY; PH; PRECIPITATION; PRIORITY JOURNAL;

EID: 0029978562     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04443-2     Document Type: Article

References (27)

1. Bartoli, H.-M., Boitard, M., Fessi, H., Beriel, H., Devissagnet, J-P., Picot, F. and Puisien, F., In vitro and in vivo antitumoral activity of free and encapsulated taxol. J. Microencap., 7 (1990) 191-197.
2. Burt, H.M., Jackson, J.K., Sarvjeet, B.K, Liggins, R.T., Oktaba, A-M., Arsenault, L.A. and Hunter, W.L., Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly(d,l-lactic acid). Cancer Lett., 88 (1995) 73-79.
3. Cserhati, T. and Hollo, J., Interaction of taxol and other anticancer drugs with hydroxypropyl-β-cyclodextrin. Int. J. Pharm., 108 (1994) 64-75.
4. Dordunoo, S.K., Jackson, J.K., Arsenault, L.A., Oktaba, A.M.C., Hunter, W.L. and Burt H.M., Taxol encapsulation in poly(∈-caprolactone) microspheres. Cancer Chemother. Pharmacol., 36 (1995) 279-282.
5. Estes, K.S., Brewster, M.E., Webb, A.I. and Bodor N., A non-surfactant formulation for alfaxalone based on an amorphous cyclodextrin. Activity studies in rats and dogs. Int. J. Pharm., 65 (1991) 101-107.
6. Higuchi, T. and Connors, K.A., Phase solubility techniques. Adv. Anal. Chem. Instrum., 4 (1965) 117-212.
7. Huang, C.H.O., Kingston, D.G.I., Magri, N.F., Samaranayake G. and Boettner, F.E., New taxanes from Taxus brevifolia, 2. J. Nat. Prod., 49 (1986) 665-669.
8. Kerns, E.H., Volk, K.J. and Hill, S.E., Profiling taxanes in Taxus extracts usingLC/MS and LC/MS/MS techniques. J. Nat. Prod., 57, (1994) 1391-1403.
9. Kingston, D.G.I., Samaranayake, G. and Ivey, C.A., The chemistry of taxol, a clinically useful anticancer agent. J. Nat. Prod., 53 (1990), 1-12.
10. Lataste, H., Senilh, V., Wright, M., Guenard, D. and Potier, P., Relationship between the structures of taxol and baccatin III derivatives and their in vitro action on the disassembly of mammalian brain and physarum amoebal microtubules. Proc. Natl. Acad. Sci. USA., 81 (1984) 4090-4094.
11. Magri, N.F. and Kingston, D.G.I., Modified taxols: Oxidation products of taxol. J. Org. Chem., 51 (1986) 797-802.
12. Parness, J., Kingston, D.G.I., Powell, R.G., Harracksingh, C. and Horwitz, S.B., Structure activity stduy of cytotoxicity and microtubule assembly in vitro by taxol and related taxanes. Biochem. Biophys. Res. Commun., 105 (1982) 1082-1089.
13. Ringel, I and Horwitz, S.B., Taxol is converted to 7-epi-taxol, a biologically active isomer in cell culture medium. J. Pharmacol. Exp. Ther., 242 (1987) 692-698.
14. Schiff, P.B., Fant, J. and Horwitz, S.B., Promotion of microtubule assembly in vitro by taxol. Nature, 277 (1979) 665-667.
15. Sharma, A. and Straubinger, R.M., Novel taol formualtions: Preparation and characterization of Taxol-containing liposomes. Pharm. Res., 11 (1994) 889-896.
16. Sharma, U.S., Balasubramanian, S.V. and Straubinger, R.M., Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins. J. Pharm. Sci., 84 (1995) 1223-1230.
17. Shefter, E. and Higuchi, T., Dissolution behaviour of crystalline solvated and nonsolvated forms of some pharmaceuticals. J. Pharm Sci., 52 (1963) 781-791.
18. Szejtli, J., Cyclodextrins in Drug formulations. Pharm. Technol. Int. 3(2) (1991) 15-22 and 3(3) (1991) 16-24.
19. Szejtli, J., Cyclodextrins in Drug formulations. Pharm. Technol. Int. 3(2) (1991) 15-22 and 3(3) (1991) 16-24.
20. Tarr, B.D., Sambandan, T.G. and Yalkowsky, S.H., A new parenteral emulsion for the administration of taxol. Pharm. Res., 4 (1987) 162-165.
21. Tokumura, T., Nanba, M., Tsushima, Y., Tatsuishi, K., Kayano, M., Machida, Y. and Yagai, T., Enhancement of bioavailability of cinnarizine from its β-cyclodextrin complex on oral administration with DL-phenylalanine as a competing agent. J. Pharm. Sci., 75 (1986) 391-394.
22. Torres-Labandeira, J.J., Davignon, P. and Pitha, J., Oversaturated solutions of drug in hydroxypropylcyclodextrins: Parenteral preparation of pancratistatin. J. Pharm. Sci., 80 (1991) 384-386.
23. Uekama, K. and Otagiri, M., Cyclodextrins in drug carrier systems (Review). CRC Crit. Rev. Ther. Carrier Sys., 3 (1987) 1-40.
24. Uekama, K., Narisawa, S., Hirayama, F. and Otagiri, M., Improvement of dissolution and absorption characteristics of benzodiazpines by cyclodextrin complexation. Int. J. Pharm., 16 (1983) 327-338.
25. Uekama, K., Hirayama, F. and Irie, T. Application of cyclodextrins. In de Boer, A.G. (Ed.), Drug absorption enhancement: concepts, possibilities, limitations and trends, Harwood Academic Publishers, Langhorne PA, 1994, pp. 411-456.
26. Wani, M.C., Taylor, H.L., Wall, M.E., Coggon, P. and McPhail, A.T., Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc., 93 (1971) 2325-2337.
27. Waugh, W.N., Trissel, L.A. and Stella, V.J., Stability, compatibility and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers. Am. J. Hosp. Pharm., 48 (1991) 1520-1544.